An Inflammation‐Associated Control Mechanism of Allergy by Proteolysis of IgE
Allergy · 2025
DOI: 10.1111/all.16622 ↗At a glance
Journal article in Allergy, 2025. Written by Estefania Ugarte-Berzal and 10 co-authors. Institution: Department of Microbiology, Immunology and Transplantation, Laboratory of Immunobiology, Rega Institute for Medical Research, KU Leuven, Leuven, Belg…. Major MEDLINE topics: Immunoglobulin E, Proteolysis, Inflammation, Hypersensitivity. 68 references. Funded by: Onderzoeksraad, KU Leuven, Fonds Wetenschappelijk Onderzoek, Novartis Pharma.
Abstract (original language)
Background
Adaptive IgE‐mediated reactions are faster than immune responses that depend on IgM, IgA, and IgG. Normal serum IgE concentrations are highly variable among individuals and extremely low in comparison with those of IgM and IgG. Omalizumab is a clinically approved monoclonal antibody that selectively binds free IgE, preventing allergy‐specific IgE from binding to FcεRI expressed on mast cells and basophils, thereby inhibiting degranulation and mediator release. We aimed to evaluate proteolysis of IgE within the contexts of acute inflammations in vitro and in patient samples and the biological effects of resulting IgE proteoforms.
Methods
IgE was subjected in vitro to neutrophil proteases. Biochemical and biological IgE proteoform identification was performed and IgE receptor binding capacity and abundance in patient samples were evaluated.
Results
Whereas IgG, IgA, and IgM are neutrophil protease‐resistant, the IgE heavy chain was cleaved in a bait region by these inflammation‐associated proteases. The cleavages occurred on both free and CD23‐bound IgE; however, not with FcεRI‐bound IgE. Proteolysis generated two proteoforms: a large IgE cleavage fragment (IgEcl) and a smaller IgE carboxyterminal truncation fragment Cεtr. Proteolysed IgE did not bind to its receptors. The Cεtr fragment shared with chemokines high affinity to glycosaminoglycans (GAGs) and synergistically attracted neutrophils. The discovered bait region in IgE corresponded with a shared epitope recognized by omalizumab, and omalizumab prevented IgE proteolysis. Both IgEcl and Cεtr were present in plasma samples from patients suffering from IgE‐mediated allergies, chronic spontaneous urticaria, and more abundantly in atopic dermatitis (AD) patients.
Conclusions
This work reveals new mechanistic insights into the immunobiology of IgE and the action of omalizumab with potential clinical impacts. Indeed, IgE‐specific cleavage by inflammation‐associated granulocyte proteinases may be an important feedback mechanism to control allergic responses.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Microbiology, Immunology and Transplantation, Laboratory of Immunobiology, Rega Institute for Medical Research, KU Leuven, Leuven, Belgium.
- Department of Microbiology, Immunology and Transplantation, Laboratory of Molecular Immunology, Rega Institute for Medical Research, KU Leuven, Leuven, Belgium.
- Department of Microbiology, Immunology, and Transplantation, Allergy and Clinical Immunology Research Group, KU Leuven, Leuven, Belgium.
- Department General Internal Medicine-Allergy and Clinical Immunology, University Hospitals Leuven, Leuven, Belgium.
- Immunology Disease Area, Novartis BioMedical Research, Basel, Switzerland.
ORCID profiles: Estefania Ugarte-Berzal
Funding
- Onderzoeksraad, KU Leuven
- Fonds Wetenschappelijk Onderzoek
- Novartis Pharma
- Rega Foundation
Cite
APA
Ugarte-Berzal, E., Martens, E., Pereira, R. V. S., Wets, D., Ganseman, E., Gouwy, M., Breynaert, C., Guntermann, C., Schrijvers, R., Proost, P., & Opdenakker, G. (2025). An Inflammation‐Associated Control Mechanism of Allergy by Proteolysis of IgE. Allergy. https://doi.org/10.1111/all.16622
Vancouver
Ugarte-Berzal E, Martens E, Pereira RVS, Wets D, Ganseman E, Gouwy M, et al. An Inflammation‐Associated Control Mechanism of Allergy by Proteolysis of IgE. Allergy. 2025. doi:10.1111/all.16622
BibTeX
@article{UgarteBerzal2025,
author = {Ugarte-Berzal, Estefania and Martens, Erik and Pereira, Rafaela Vaz Sousa and Wets, Dries and Ganseman, Eva and Gouwy, Mieke and Breynaert, Christine and Guntermann, Christine and Schrijvers, Rik and Proost, Paul and Opdenakker, Ghislain},
title = {An Inflammation‐Associated Control Mechanism of Allergy by Proteolysis of IgE},
journal = {Allergy},
year = {2025},
doi = {10.1111/all.16622}
}
EUVIMED